889940-13-0 | 3,3,3-Trifluoro-2,2-dimethylpropanoic acid

CAS:889940-13-0 | 3,3,3-Trifluoro-2,2-dimethylpropanoic acid ,Description

3,3,3-Trifluoro-2,2-dimethylpropanoic acid, also known as TFDMP, is a synthetic organic compound with a wide range of applications in the fields of chemistry and biochemistry. It is a colorless liquid with a boiling point of 74.6°C and a melting point of -87.2°C. It is soluble in water and is used as an intermediate in the synthesis of other compounds. TFDMP has been used in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds.
 

Scientific Research Applications

• Synthesis of Dual Inhibitors: This compound is utilized in the synthesis of 2-aminobenzaldehyde oxime analogs. These analogs act as dual inhibitors of neutrophil elastase and proteinase, enzymes involved in various biological processes. The inhibition of these enzymes can be crucial in the study and treatment of various diseases, making this application significant in medical research and pharmaceutical development (source: Thermo Fisher Scientific).
• Decarboxylative Fluoroalkylation: It plays a role in the transition metal-free decarboxylative fluoroalkylation of activated alkenes. This process is important for constructing 1,1-dimethyl-2,2,2-trifluoroethyl substituted oxindoles, compounds that have potential applications in drug discovery. This method is noteworthy for its efficiency and the ability to yield products that might have pharmaceutical relevance (source: Royal Society of Chemistry Publishing).
• Preparation of Heteroarenes: The compound is instrumental in the direct synthesis of C(CF3)Me2-substituted heteroarenes through a decarboxylative 1,1-dimethyltrifluoroethylation process. This process does not require a transition-metal catalyst and has been used to produce a series of previously unknown C(CF3)Me2-containing heteroarenes. These heteroarenes have potential applications in drug discovery, highlighting the compound's importance in the synthesis of new chemical entities that could lead to novel therapeutics (source: PubMed).

More Information